mTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells
AUTOR(ES)
Murakami, Mirei
FONTE
American Society for Microbiology
RESUMO
TOR is a serine-threonine kinase that was originally identified as a target of rapamycin in Saccharomyces cerevisiae and then found to be highly conserved among eukaryotes. In Drosophila melanogaster, inactivation of TOR or its substrate, S6 kinase, results in reduced cell size and embryonic lethality, indicating a critical role for the TOR pathway in cell growth control. However, the in vivo functions of mammalian TOR (mTOR) remain unclear. In this study, we disrupted the kinase domain of mouse mTOR by homologous recombination. While heterozygous mutant mice were normal and fertile, homozygous mutant embryos died shortly after implantation due to impaired cell proliferation in both embryonic and extraembryonic compartments. Homozygous blastocysts looked normal, but their inner cell mass and trophoblast failed to proliferate in vitro. Deletion of the C-terminal six amino acids of mTOR, which are essential for kinase activity, resulted in reduced cell size and proliferation arrest in embryonic stem cells. These data show that mTOR controls both cell size and proliferation in early mouse embryos and embryonic stem cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=444840Documentos Relacionados
- Disruption of the Mouse mTOR Gene Leads to Early Postimplantation Lethality and Prohibits Embryonic Stem Cell Development
- FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse
- ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy*S⃞
- mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo
- Targeting the Notch1 and mTOR pathways in a mouse T-ALL model